General Information

All information about registration will coming soon...

For more information, please send an email to microbiota(at)microbiota-site.com

ISM Scientific Board

President of ISM:
Peter C. Konturek, Teaching Hospital of the University of Jena, Germany

Founder and Executive Chairman:
Marvin Edeas, Institut Cochin, INSERM U1016, Paris Descartes University, France

ISM Scientific Steering Board:
Peter C. Konturek, Teaching Hospital of the University of Jena, Germany
Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, France
Markus Egert, Furtwangen University, Germany
Paul Forsythe, McMaster University, Canada
Ernst Holler,  Medical Center Regensburg University, Germany
Carole Nicco, Institut Cochin - INSERM U1016, Université Paris Descartes, France
Maria Cecilia Giron, University of Padua, Italy
Chantal Pichon, French National Centre for Scientific Research, France
Roberto Pacifici, Emory University, USA
Annalisa Terranegra, Sidra Medicine, Qatar
Heenam Stanley Kim, College of Health Sciences, Korea University, Republic of Korea
Henri Jasper, Buck Institute, USA
Howard Weiner, Harvard University, USA
Matteo Serino, Inserm and Digestive Health Research Institute, France
Marcin Ufnal, Medical University of Warsaw, Poland
Jakub Piwowarski,  Medical University of Warsaw, Poland

Welcome to the 4th World Congress on Targeting Microbiota

Dear Colleagues, 

It is our pleasure to announce the 4th World Congress on Targeting Microbiota which will be held at Institut Pasteur in Paris, France on October 17-19, 2016. 

A substantial amount of evidence has shown that a diverse population of micro-organisms live in our skin, mouth, nose, lungs and intestines, where they play a strategic role in regulating and possibly controlling human health, well-being, metabolism and diseases.

Among Targeting Microbiota 2016 sessions selected by the scientific committee: 

• Microbiota 2016: Recent Advances & Perspectives
• Microbiota analysis 2016: The challenge of big data interpretation
• Skin Microbiota: Recent advances and perspectives
• Challenges to control the diversity and quality of microbiota by:
  • Phage therapy
  • Diet, probiotics and prebiotics
  • CRISPR/Cas system
  • Quorum sensing
  • Fecal Microbiota Transplantation: Clinical & Practical Issues

To conclude this congress, a general discussion on Microbiota and the medicine of tomorrow will be held between speakers, scientists and industrials.

We hope that you will join us for this special program and look forward to welcoming you in Paris.

Yuri Ikeda - Chairman of the International Society of Microbiota

ISM Scientific Board

President of ISM
Maria Cecilia Giron, University of Padova, Italy

Founder and Executive Chairman
Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, France

ISM Scientific Steering Board
Markus Egert, Furtwangen University, Germany
Ramakrishna Kommagani, Baylor College of Medicine, USA
Peter C. Konturek, Teaching Hospital of the University of Jena, Germany
Lena Öhman, University of Gothenburg, Sweden
Karl-Herbert Schäfer, Kaiserlautern University of Applied Sciences, Germany
Andreas Schwiertz, Institute of Microecology, Germany
Matteo Serino, Inserm and Digestive Health Research Institute, France
Annalisa Terranegra, Sidra Medicine, Qatar